Skip to main content
. 2017 Oct 24;117(11):1723–1731. doi: 10.1038/bjc.2017.347

Figure 3.

Figure 3

Risks of adverse health events after acute lymphoblastic leukaemia. (A) Observed and expected risks of any subsequent primary neoplasm after acute lymphoblastic leukaemia. incl=including; NGCNS=Non-glioma central nervous system tumours; NMSC=non-melanoma skin cancer; obs=observed. The cross bars are 95% CI. Log-rank test for equality of observed risks comparing Levels 2 and 3 yields P=0.2052. (B) Observed and expected risks of any fatal non-neoplastic event after acute lymphoblastic leukaemia. Log-rank test for equality of observed risks comparing Levels 2 and 3 yields P=0.0018. (C) Observed risks of any non-fatal non-neoplastic condition after acute lymphoblastic leukaemia. Log-rank test for equality of observed risks comparing Levels 2 and 3 yields P=0.0002.